AML treatment: conventional chemotherapy and emerging novel agents
M Forsberg, M Konopleva - Trends in Pharmacological Sciences, 2024 - cell.com
Acute myeloid leukemia (AML) is driven by complex mutations and cytogenetic
abnormalities with profound tumoral heterogeneity, making it challenging to treat. Ten years …
abnormalities with profound tumoral heterogeneity, making it challenging to treat. Ten years …
Stem Cell-Derived Cell Therapy for Cancer
M Wilson, Z Lyu, Y Fang, YR Li - 2023 - Springer
The advent of genetic engineering strategies has transformed the landscape of cancer
immunotherapy, leading to the development and adoption of CAR-T cell therapy. However …
immunotherapy, leading to the development and adoption of CAR-T cell therapy. However …